Examination: The patient did not appear to be dyspnoeic, cyanosed or anaemic. The pulse rate was 70/min and irregular in time and volume in erect and supine positions. He had weak pulsation on both dorsalis pedes and posterior tibials. The blood pressure was 170/70mmHg in the supine position and 130/70mmHg standing. The lung bases were clear. The apex beat of the heart was not palpable.
The S1 was of variable intensity and S2 was normal.
There was a short basal ejection systolic murmur. Neurologic examination revealed signs of sensory and autonomic neuropathy. The patient's pupils were contracted and reacted sluggishly to light. The Patellar reflexes were present. There was loss of vibration and position sensations. There was reduction to pin prick sensation in both legs, more on the left side.
RESULTS
Haematologic and biochemical blood tests were normal, with the exception of mildly elevated fasting and postprandial blood sugar levels. Serological tests for syphillis were negative. The chest x ray showed clear lung fields, with a CT-ratio of 55%. The electrocardiogram revealed atrial flutter with a ventricular response of 70/min. Deep S waves were present in V5 and V6. Atrial fibrillation emerged during an episode of chest pain associated with rapid ventricular response, ST-depression in I, aVL, V4-V6 and a poor progression of the R-waves in the V-leads. He was treated with increasing doses of isosorbide dinitrate (10mg tid up to 40mg tid) in addition to sublingual glycerine trinitrate as needed.
The patient reported some relief but still complained of chest pain. Although addition of nifedipine (10-20mg tid) alleviated the chest pain, the patient's heart rate dropped with 20mg tid and he reported dizzy spells. Upon examination his heart rate was 30-40/min and irregular, with a supine blood pressure of 120/70mmHg and a pressure of 80/60mmHg while standing. Pace maker wire was inserted and he was paced at 70/min, which resolved the dizziness, however his chest pain recurred when nifedipine was discontinued.
Reintroduction of nifedipine during pacing controlled the chest pain.
The electrocardiogram showed atrialflutter/fibrillation with slow ventricular response, which improved when nifedipine was discontinued. These findings reappeared when nifedipine therapy resumed.
A permanent pacemaker was implanted and fixed at a demand rate of 70/min. The patient's chest pain was controlled with nifedipine (20mg tid) and isosorbide dinitrate (20mg tid). Glycerine trinitrate was administered on demand.
DISCUSSION
Nifedipine facilitates A-V nodal conduction which probably reflects action of a sympathetic mechanism triggered by peripheral vasodilatation and hypotension.
In rabbits small intravenous doses of nifedipine (3mg/kg body weight) elicited enhanced A-V nodal conduction in the normally innervated heart, and had no detrimental effects in hearts deprived of compensatory sympathetic drive by bilateral stellate ganglionectomy . At higher doses (30mg/kg body weight), A-V conduction was unaffected as long as the sympathetic nerve supply to the heart was intact. However, after interruption of sympathetic nerves, in both the A-V nodal conduction time and the A-V nodal functional refractory period in animal experiments,6),7) nifedipine has a definite depressant effect on A-V nodal conduction, which is a dose dependent effect. This is compatible with that of verapamil and diltiazem.8)
Our patient has very suggestive signs and symptoms of autonomic neuropathy such as postural blood pressure changes, no response of the heart rate to postural changes, intermittent diarrhoea, sweating during meals and sluggish pupillary reflexes. His heart rate was slowed by nifedipine. Increased doses produced dizziness and bradycardia which were resolved when the drug was discontinued. We believe that nifedipine caused bradycardia in this patient with cardiac autonomic neuropathy.
To our knowledge there is only one previous report of bradycardia after nifedipine administration.9)
The previously reported case10) was a patient with accelerated hypertension and heart failure. There were no other clinical notes on that case and there was no electrocardiographic evidence of bradycardia to support this effect.
